Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial M. Lichtblau; S. Saxer; J. Müller; P. Appenzeller; C. Berlier; S.R. Schneider; L. Mayer; M. Furian; E.I. Schwarz; E.R. Swenson; K.E. Bloch; S. Ulrich;

Severity of precapillary pulmonary hypertension: Predictive factor J.A. de Barros; G. Sant¿Ana; G. Martins; L. Madlum; C. Scremim; R. Petterle; D. Escuissato; E. Lima;

Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis P.C. Mota; M.L. Soares; A.C. Ferreira; R.F. Santos; J.C. Rufo; D. Vasconcelos; A. Carvalho; S. Guimarães; F. Vasques-Nóvoa; C. Cardoso; N. Melo; A.T. Alexandre; D. Coelho; H. Novais-Bastos; A. Morais;